Immunogenetics and Transplantation Laboratory, Department of Surgery, University of California San Francisco, San Francisco, CA, USA.
BioExIn, Delhi, India.
J Pharmacol Sci. 2023 May;152(1):1-21. doi: 10.1016/j.jphs.2023.02.004. Epub 2023 Feb 15.
The coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The infection is caused when Spike-protein (S-protein) present on the surface of SARS-CoV-2 interacts with human cell surface receptor, Angiotensin-converting enzyme 2 (ACE2). This binding facilitates SARS-CoV-2 genome entry into the human cells, which in turn causes infection. Since the beginning of the pandemic, many different therapies have been developed to combat COVID-19, including treatment and prevention. This review is focused on the currently adapted and certain other potential therapies for COVID-19 treatment, which include drug repurposing, vaccines and drug-free therapies. The efficacy of various treatment options is constantly being tested through clinical trials and in vivo studies before they are made medically available to the public.
2019 年冠状病毒病(COVID-19)是由严重急性呼吸系统综合征冠状病毒 2(SARS-CoV-2)引起的。当 SARS-CoV-2 表面的刺突蛋白(S 蛋白)与人类细胞表面受体血管紧张素转化酶 2(ACE2)相互作用时,就会引发感染。这种结合促进了 SARS-CoV-2 基因组进入人体细胞,进而导致感染。自大流行开始以来,已经开发出许多不同的疗法来对抗 COVID-19,包括治疗和预防。本综述重点介绍了目前针对 COVID-19 治疗的适应疗法和其他一些潜在疗法,包括药物再利用、疫苗和无药物疗法。各种治疗选择的疗效都在通过临床试验和体内研究不断进行测试,然后才能在医学上提供给公众。